Deutsche Bank Downgrades Gentiva Health Services (GTIV) to Hold; SFC Report Worse Than Expected

Article Stock Quotes (2) Comments (0)

Deutsche Bank downgraded Gentiva Health Services (NASDAQ: GTIV) from Buy to Hold, price target cut from $14 to $5.50.

Deutsche analyst says, "Today (10/03), Senate Finance Cmte (SFC) released a Staff Report on Home Health and the Medicare Therapy Threshold. While maximization of the 10-visit tx threshold (pre-2008) and the 6/14/20 tx intervals (post-2008) has been widely known, SFC reveals aggressive internal policies by major chains designed to game Medicare pmt incentives. The findings, in our view, could lead to further investigations and make it incrementally more likely worst-case Medicare rate cuts materialize. We now find it imprudent to characterize Amedisys (Nasdaq: AMED) & GTIV as over-sold."

For more ratings news on Gentiva Health Services click here and for the rating history of Gentiva Health Services click here.

Shares of Gentiva Health Services closed at $3.68 yesterday, with a 52 week range of $3.50-$29.21.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Exane BNP Paribas Downgrades BlackBerry (BBRY) to Underperform; Analyst Says Profit 'Drying Up'
• UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
• Roth Capital Downgrades Acquity Group (AQ) to Neutral

Create E-mail Alert Related Categories

Downgrades

Related Entities

Deutsche Bank

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?